ChiCTR2300078597 版本V1.0 版本创建时间2023/12/13 11:20:30 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300078597 

最近更新日期:

Date of Last Refreshed on:

2023-12-13 11:20:00 

注册时间:

Date of Registration:

2023-12-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

正念减压疗法在恶性血液病住院患者中的应用研究

Public title:

Application of mindfulness-based decompression therapy in hospitalized patients with malignant hematological diseases

注册题目简写:

English Acronym:

研究课题的正式科学名称:

正念减压疗法在恶性血液病住院患者中的应用研究

Scientific title:

Application of mindfulness-based decompression therapy in hospitalized patients with malignant hematological diseases

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郑秀 

研究负责人:

于俊叶 

Applicant:

Xiu Zheng 

Study leader:

Junye Y 

申请注册联系人电话:

Applicant telephone:

+86 184 0499 6103

研究负责人电话:

Study leader's telephone:

+86 150 1121 0927

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

314191725@qq.com

研究负责人电子邮件:

Study leader's E-mail:

handanyujy@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区玉泉路15号航天中心医院

研究负责人通讯地址:

北京市海淀区玉泉路15号航天中心医院

Applicant address:

Aerospace Center Hospital, 15 Yuquan Road, Haidian District, Beijing

Study leader's address:

Aerospace Center Hospital, 15 Yuquan Road, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

航天中心医院

Applicant's institution:

Aerospace Center Hospital

研究负责人所在单位:

航天中心医院

Affiliation of the Leader:

Aerospace Center Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

京航医伦审 2022第(010)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

航天中心医院医学伦理委员会

Name of the ethic committee:

Aerospace Center Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023-04-02 00:00:00

伦理委员会联系人:

时瀚

Contact Name of the ethic committee:

HanShi

伦理委员会联系地址:

北京市海淀区玉泉路15号航天中心医院

Contact Address of the ethic committee:

Aerospace Center Hospital, 15 Yuquan Road, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 5997 1956

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

航天中心医院

Primary sponsor:

Aerospace Center Hospital

研究实施负责(组长)单位地址:

北京市海淀区玉泉路15号航天中心医院

Primary sponsor's address:

Aerospace Center Hospital, 15 Yuquan Road, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

海淀区

Country:

China

Province:

BeiJing

City:

Haidian District

单位(医院):

航天中心医院

具体地址:

北京市海淀区玉泉路15号航天中心医院

Institution
hospital:

Aerospace Center Hospital

Address:

Aerospace Center Hospital, 15 Yuquan Road, Haidian District, Beijing

经费或物资来源:

首都卫生发展科研专项项目

Source(s) of funding:

Capital health development research project

Target disease:

hematological malignancies

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究以正念减压疗法为理论指导,以恶性血液病患者为研究对象,在充分调研恶性血液病住院患者的心理状况的基础上,构建恶性血液病患者针对性的正念减压疗法;并通过临床实践验证正念减压疗法对恶性血液病住院患者焦虑抑郁及生活质量的干预效果,以全面改善恶性血液病住院患者术后化疗患者的整体生活质量,为临床医护人员对恶性血液病患者进行心理护理及院内康复指导提供依据。  

Objectives of Study:

Based on the theoretical guidance of mindfulness-based decompression therapy and the research object of patients with malignant hematological diseases, this study constructs the targeted mindfulness-based decompression therapy for patients with malignant hematological diseases on the basis of fully investigating the psychological status of hospitalized patients with malignant hematological diseases. Moreover, the effect of mindfulness-based decompression therapy on anxiety, depression and quality of life of hospitalized patients with malignant hematologic diseases was verified through clinical practice, so as to comprehensively improve the overall quality of life of hospitalized patients with malignant hematologic diseases after postoperative chemotherapy, and provide a basis for clinical medical staff to carry out psychological nursing and in-hospital rehabilitation guidance for patients with malignant hematologic diseases.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄大于18岁小于60岁的患者; ②疾病诊断为恶性血液病; ③对疾病诊断知情; ④预计生存期≥1年 ⑤意识清楚,理解并能够对问卷问题进行作答; ⑥同意参与本研究。

Inclusion criteria

① Patients older than 18 years and younger than 60 years; ② The disease was diagnosed as hematologic malignancy; ③ Knowledge of disease diagnosis; ④ Expected survival ≥1 year ⑤ Clear awareness, understanding and able to answer the questionnaire questions; ⑥ Agree to participate in this study.

排除标准:

①病情严重或合并有其他严重躯体疾病者; ②伴有精神疾病或认知障碍者。

Exclusion criteria:

① Patients with serious illness or other serious physical diseases; ② People with mental illness or cognitive impairment.

研究实施时间:

Study execute time:

From 2022-01-01 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-12-15 00:00:00 To 2024-05-31 00:00:00  

干预措施:

Interventions:

组别:

干预组

样本量:

48

Group:

Intervention group

Sample size:

干预措施:

第一周:初尝正念,觉察生命玄妙之门——正念呼吸 第二周:接纳身体,进入无条件的爱——身体扫描 第三周:与情绪共处,汇聚散乱之心——调控情绪 第四周:活在当下,安住于此——正念静坐 第五周:本就可以,不用太用力——正念伸展 第六周:善待自己,从一日三餐开始——正念饮食 第七周:随心而行,路途在迎接你——步行冥想 第八周:涅槃重生,创造无限可能——正念生活

干预措施代码:

Intervention:

Week 1: First taste of mindfulness, awareness of the mysterious door of life - mindful breathing Week 2: Accept the body into unconditional love - Body Scan Week 3: Live with your emotions, gather your scattered mind - regulate your emotions Week 4: Be present, be settled in the present moment - mindful meditation Week 5: Can do, don't push too hard - mindfulness stretching Week 6: Treat yourself by starting with three meals a day - mindful eating Week 7: Follow your heart, the path is waiting for you - walking meditation Week 8: Nirvana reborn to create infinite possibilities - mindful living

Intervention code:

组别:

对照组

样本量:

48

Group:

Control group

Sample size:

干预措施:

常规对恶性血液病住院患者进行住院护理。主要内容包括: 由主管医生、护士长和责任护士分别评估患者病情,一般包含患者的年龄、文化程度、目前化疗时间及频率、是否存在原发病及对自身疾病的认知程度等首先责任护士进行自我介绍,然后为患者进行病室环境布局的现场讲解;通过发放宣传手册、组织观看健康教育视频等,进一步帮助增强患者对恶性血液病治疗的原理、方法、意义的了解,对患者穿刺、建立血管通路,对可能出现的问题及注意事项提前告知;最后指导及协助患者完成相关的检查及时与患者进行沟通,把握其心理动态,通过适当的交流和心理疏导达到缓解患者不良情绪,并以积极心态配合治疗的目的。

干预措施代码:

Intervention:

The patients with malignant hematological diseases were routinely nursed in hospital. The main contents include: The doctor in charge, the head nurse and the responsible nurse respectively evaluate the patient's condition, which generally includes the patient's age, education level, current time and frequency of chemotherapy, whether there is primary disease and the degree of cognition of their own disease. The responsible nurse first introduces herself, and then explains the layout of the ward environment for the patient on the spot. By distributing publicity brochures and organizing watching health education videos, we can further help to enhance patients' understanding of the principles, methods and significance of the treatment of malignant hematological diseases, and inform patients of possible problems and precautions in advance of puncture and establishment of vascular access. Finally, guide and assist the patient to complete the relevant examination, communicate with the patient in time, grasp the psychological dynamics of the patient, relieve the patient's bad mood through appropriate communication and psychological counseling, and cooperate with the treatment with a positive attitude.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

海淀区 

Country:

China 

Province:

BeiJIng 

City:

 

单位(医院):

航天中心医院 

单位级别:

三级 

Institution
hospital:

Aerospace Center Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

焦虑抑郁

指标类型:

主要指标

Outcome:

anxiety-depression

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失眠

指标类型:

主要指标

Outcome:

insomnia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

主要指标

Outcome:

life quality

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

正念觉知

指标类型:

主要指标

Outcome:

Mindfulness awareness

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

nothing

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

选取我院2023年12月15日-2024年5月31日血液科符合纳入和排除标准的恶性血液病患者,按患者入院顺序对入组患者编号,由研究者采用信封法,随机分为干预组和对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients with malignant hematologic diseases who met the inclusion and exclusion criteria in the hematology department of our hospital from December 15, 2023 to May 31, 2024 were selected, numbered according to the order of admission, and randomly divided into the intervention group and the control group by using the envelope method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://www.chictr.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.chictr.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究者通过问卷采集后进行数据录入,双人核对录入Excel表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

After the questionnaire collection, the researcher entered the data, and double-checked the data into the Excel table

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-12-13 11:20:00